CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 12,867 shares, a drop of 13.1% from the January 15th total of 14,803 shares. Based on an average trading volume of 823,759 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 823,759 shares, the days-to-cover ratio is presently 0.0 days.
CV Sciences Stock Performance
CV Sciences stock opened at $0.05 on Wednesday. CV Sciences has a 1-year low of $0.02 and a 1-year high of $0.10. The company has a quick ratio of 0.21, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The firm’s 50 day simple moving average is $0.05 and its 200 day simple moving average is $0.04.
CV Sciences Company Profile
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
See Also
- Five stocks we like better than CV Sciences
- Energy Security Is Now National Security – Positioning Is Happening Now
- The gold chart Wall Street is terrified of…
- Have $500? Invest in Elon’s AI Masterplan
- Your Bank Account Is No Longer Safe
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
